Control, Fludrocortisone or Midodrine for the treatment of Orthostatic Hypotension: A Randomised Controlled Trial

Welcome to the CONFORM-OH trial

The CONFORM-OH trial is complete and the results have been published in Pilot and Feasibility (link to paper https://pubmed.ncbi.nlm.nih.gov/41013707/) and as an NIHR  synopsis (link https://pubmed.ncbi.nlm.nih.gov/41217271/). A lay summary is provided in the news section.

Sponsor: Newcastle upon Tyne Hospitals NHS Foundation Trust (NuTH)

Funder: National Institute for Health Research (NIHR) Health Technology Assessment programme

Trial Management: Newcastle Clinical Trials Unit (NCTU) - a fully registered UKCRC Clinical Trials Unit

This study is funded by the National Institute of Health Research (NIHR) Health Technology Assessment (HTA) programme (NIHR127385). The views expressed are those of the authors and not necessarily those of the NIHR, the Department of Health and Social Care. 

The information on this website is for UK Healthcare Professionals only.